Whole genome sequencing

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Whole exome sequencing (WGS) is a form of genetic testing that maps all the nucleotides in a person's DNA, offering the possibility of identifying variations in any part of the genome.[1] As of 2017, researcher Liz Worthey's lab charged $6,500 for WGS.[2]

See also[edit | edit source]

References[edit | edit source]

  1. Reference, Genetics Home. "What are whole exome sequencing and whole genome sequencing?". Genetics Home Reference. U.S. National Library of Medicine. Retrieved January 13, 2019.
  2. Mullin, Emily. "Patients face a frustrating diagnostic odyssey when genome sequencing doesn't provide an answer". MIT Technology Review. Retrieved March 29, 2019.